It is important to note that in our analysis, if using gene mutation data alone, none of the genes in the positively regulating FFL would have been identified, since the mutation frequency of PDGF-D, FLT1, and SHC1 are very low across all breast cancer samples. This evidence concerns the gene FLT1 and breast carcinoma.